Enidal, Haimah G.
HRN: 22-94-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/15/2025
04/22/2025
ORAL
5 Ml
Every 12 Hours
T/c Anaerobic Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes